Ignite Creation Date:
2024-05-06 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03590236
Status:
UNKNOWN
Last Update Posted:
2018-07-18
First Post:
2017-09-07
Brief Title:
Graded Exposure Therapy in Chronic Pelvic Pain
Sponsor:
Universidad de Granada
Organization:
Universidad de Granada
Study Overview
Official Title:
Graded Exposure Therapy in Women With Chronic Pelvic Pain
Status:
UNKNOWN
Status Verified Date:
2018-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chronic pelvic pain CPP is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis The objective of this study was to evaluate the effects of graded exposure therapy in women with chronic pelvic pain
Detailed Description:
Chronic pelvic pain CPP is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis This condition lasts at least 6 months and many times is associated with negative cognitive emotional sexual and behavioral consequencesIn addition to the high economic cost CPP is also costly in emotional and psychological suffering This clinical trial aims to evaluate the effects of a program based on graded exposure therapy in women with chronic pelvic pain
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None